Research Article

Factors Associated with Poor Treatment Outcome among Hospitalized COVID-19 Patients in South Central, Ethiopia

Table 3

Bivariate and multivariate logistic regression analysis of factors associated with the treatment outcome of COVID-19 patients, 2021.

CategoriesTreatment outcomeCOR (95% CI)AOR (95% CI)
Favourable (%)Poor (%)

Age
 0-24 year91 (92.9)7 (7.1)11
 25-34year85 (93.4)6 (6.6)2.12 (0.61,7.36)0.83 (0.18,3.94)
 35-44 years49 (87.5)7 (12.5)3.95 (1.15,13.64)1.06 (0.24,4.61)
 45-54 years43 (84.3)9 (15.7)4.16 (1.20,14.36)2.64 (0.62,11.16)
 55 and above years69 (68.3)32 (31.7)4.77 (1.62,14.07)4.35 (1.30,14.60)
Sex
 Female137 (85.1)24 (14.9)0.95 (0.54,1.66)1.14 (0.56,2.34)
 Male200 (84.4)37 (15.6)11
Residence
 Rural132 (87.4)19 (12.6)11
 Urban205 (83. 0)42 (17.0)1.42 (0.79,2.55)1.26 (0.62,2.57)
Hypertension
 Yes40 (76.9)12 (23.1)1.82 (0.89, 3.71)1.58 (0.68,3.69)
 No297 (85.8)49 (14.2)11
Chronic cardiac disease
 Yes26 (76.47)8 (23.53)1.81 (0.78,4.20)2.46 (0.85,7.09)
 No311 (85.4)53 (14.6)11
COPD
 Yes32 (58.2)23 (41.8)5.78 (3.06,10.87)5.62 (2.49,12.70)
 No305 (88.9)38 (11.1)11
Asthma
 Yes32 (68.1)15 (31.9)3.11 (1.56,6.18)2.80 (1.17,6.67)
 No305 (86.9)46 (13.1)11
CKD
 Yes7 (50.0)7 (50.0)6.11 (2.06,18.11)4.81 (1.27,18.22)
 No330 (85.9)54 (14.1)11
Diabetic mellitus
 Yes73 (81.1)17 (18.9)1.27 (0.68,2.36)2.27 (1.02,5.09)
 No264 (85.7)44 (14.3)11
Malignance
 Yes10 (66.67)5 (33.33)2.92 (0.96,8.86)2.29 (0.45,11.78)
 No327 (68.9)56 (31.1)11
HIV/AIDS
 Positive6 (40.0)9 (60)9.55 (3.26,27.94)10.44 (3.0,36.35)
 Negative331 (86.4)52 (13.6)11
 Admission status
 No symptom/mild102 (96.2)4 (3.8)11
Moderate94 (90.4)10 (9.6)2.17 (0.72, 6.58)2.14 (0.58,7.93)
Severe/critical141 (75)47 (25)6.66 (2.56, 17.34)3.73 (1.17,11.95)

Note: .